NCT07481604: Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above
- State
- Under way
- Phase
- Phase 2
- People
- 135 planned
- Started
- 17 Apr 2026
- Primary completion
- Jan 2027
- Arms
- CVI-VZV-001 Low Dose, CVI-VZV-001 High Dose
- Results
- None posted
- 19 Mar 2026: Trial registered
- 17 Apr 2026: Trial started